- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07558317
The Effect of Resistance Exercise in Patients With Lower Limb Lymphedema (the LymphEx Study) (LymphEx)
The Effect of Resistance Exercise in Patients With Lower Limb Lymphedema - With and With-out Compression - a Randomized Controlled Trial (the LymphEx Study)
The aim of the study is to investigate the short-term (within 2 weeks) effects of resistance exercise with and without compression garments on lower limb lymphedema(LLL). Additionally, the study will explore the immediate response in LLL to resistance exercise (2 hours and 24 hours post-exercise).
Participants will continously wear a circumfencential sensor at the calf (CIMON from Icompression) under a compression garment and an activity tracker (SENS Motion from SENS Innovation Aps) at the thigh for 3 periods (two with supervised exercise sessions of 2 weeks and one control period).
Participants will attend supervised resistance exercise 2-3 times per week for 2 periods of 2 weeks (one with compression garment and one without). Assessments with the principal investigator will be scheduled before and after every 2 week period. Participants will keep a digital diary or diary in paper of their lymphedema related symptoms and experienced issues with the sensors or app.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Merete C Wittenkamp, PhD student
- 전화번호: 93911784
- 이메일: merete.celano.wittenkamp@regionh.dk
연구 장소
-
-
-
Herlev, 덴마크, 2730
- 모병
- Herlev and Gentofte Hospital, Department of Physiotherapy and Occupational Therapy
-
연락하다:
- Merete Wittenkamp, PhDstudent
- 전화번호: 4593911784
- 이메일: merete.celano.wittenkamp@regionh.dk
-
수석 연구원:
- Merete Wittenkamp, PhD student
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- verified diagnosis of lymphedema of the lower limb
- completed compression bandaging
- adherence to compression garment in daytime (minumum 5-6 days per week)
- calf circumference > 35 and <75 cm
Exclusion Criteria:
- severe neuropathy of the lower leg
- severe skin problems or wounds at the lower leg
- cellulitis, DVT or acute injuries of the lower limb < 2 months prior to inclusion
- ongoing adjuvant treatment for cancer
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Group A
Week 1-2 no exercise, week 3 washout, week 4-5 exercise without compression, week 6 washout, week 7-8 exercise with compression
|
Supervised resistance exercise targeted at the larger muscle groups in the lower limbs, 5 exercises, 3 sets of 10RM
|
|
실험적: Group B
Week 1-2 exercise without compression, week 3 washout, week 4-5 exercise with compression, week 6 washout, week 7-8 no exercise
|
Supervised resistance exercise targeted at the larger muscle groups in the lower limbs, 5 exercises, 3 sets of 10RM
|
|
실험적: Group C
Week 1-2 exercise with compression, week 3 washout, weekend 4-5 no exercise, week 6 washout, week 7-8 exercise without compression
|
Supervised resistance exercise targeted at the larger muscle groups in the lower limbs, 5 exercises, 3 sets of 10RM
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Lower leg circumference
기간: 14 days
|
circumferential sensor CIMON, measured in Picoferens (pF)
|
14 days
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Lower Limb volume
기간: 14 days
|
perometry, volume (mL)
|
14 days
|
|
Lower Limb volume
기간: 14 days
|
circumferential measurements, 8 cm interval, converted to volume (mL)
|
14 days
|
|
Edema of the foot and ankle
기간: 14 days
|
Figure of eight with tape measure, (cm)
|
14 days
|
|
Extracellular fluid of the lower limb
기간: 14 days
|
Bioimpedance Spectroscophy, (L-dex)
|
14 days
|
|
Body composition
기간: 14 days
|
Bioimpedance Spectroscophy, One measurement provides the following data: Total Body Water (L/%) , Extracellular fluid (L/%), Intracellular fluid (L/%), Skeletal muscle mass (kg/%), Fat mass (kg/%), Fat free mass (kg/%)
|
14 days
|
|
Segmental body composition of the lower limbs
기간: 14 days
|
Bioimpedence Spectroscophy, One measurement provides the following data: Total Body water (L), Extracellular fluid (L), Intracellular fluid (L), Skeletal Muscle Mass(kg), Lean soft tissue (kg)
|
14 days
|
|
Self reported lymphedema symptoms
기간: 14 days
|
Pain, tension, heaviness, tinkling, numeric ranking scale 0-10
|
14 days
|
|
Physical activity
기간: 14 days
|
Daily number of minutes in activity (defined as the sum of time spent with standing, walking, cycling and high intensity activity) registered by a activity sensor (SENS Motion).
Level of physical activity time per 24 hours at the following categories: lying, sitting, standing, walking, brisk walking, biking, high intensity activity
|
14 days
|
|
Adverse events
기간: 14 days
|
E.g. skin irritation, cellulitis, severe muscle injury, number of events
|
14 days
|
|
Adherence to compression
기간: 14 days
|
Adherence to compression garments = 7 days a week, yes or no, if no - number of days with compression per participant
|
14 days
|
|
Adherence to study
기간: 8 weeks
|
Completion of supervised exercise sessions and application of the sensors, number of exercise sessions attended and number of days with sensors applied per participant
|
8 weeks
|
|
Withdrawal from study
기간: 8 weeks
|
Number of participants and reasons for withdrawal
|
8 weeks
|
|
Adherence to study
기간: 8 weeks
|
Completion of supervised exercise sessions and application of the sensors, number of exercise sessions attended and number of days with sensors applied
|
8 weeks
|
공동 작업자 및 조사자
수사관
- 연구 의자: Carsten B Juhl, Professor, Herlev Gentofte Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- LymphEx
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .